In compliance with section 17(b) of the Securities Act, we are disclosing that Propanc Biopharma, Inc. (OTC: PPCB) is a client of TraDigital Marketing Group, Inc. Propanc Biopharma, Inc. has an agreement in place, dated November 30, 2023 to compensate TraDigital Marketing Group, Inc. a cash retainer of thirty thousand dollars ($30,000) for publicly disseminating information about Propanc Biopharma, Inc. via website, email, and SMS.  

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. TraDigital Marketing Group, Inc., investor awareness and advisory services include multimedia marketing and other awareness services.